𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA polymerase β gene mutation in human breast cancer

✍ Scribed by Hiroshi Miyamoto; Yohei Miyagi; Takashi Ishikawa; Yasushi Ichikawa; Masahiko Hosaka; Yoshinobu Kubota

Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
49 KB
Volume
83
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutational analysis of the p73 Gene in h
Mutational analysis of the p73 Gene in human breast cancers
✍ Tomotane Shishikura; Shingo Ichimiya; Toshinori Ozaki; Yoshinori Nimura; Hajime 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB 👁 2 views

In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region

Detection of mutations in the DNA polyme
Detection of mutations in the DNA polymerase δ gene of human sporadic colorectal cancers and colon cancer cell lines
✍ Thomas Flohr; Jia-Chun Dai; Jens Büttner; Odilia Popanda; Egbert Hagmüller; Hein 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 1 views

To test the hypothesis whether DNA polymerases acquire mutator properties during tumor development (mutator hypothesis), we examined DNA polymerase ␦ mRNA in 6 colon cancer cell lines (DLD-1, HCT116, SW48, HT29, SW480 and SW620) and 7 sporadic human colorectal cancers. For analysis we used amplifica

Pro-protein convertase gene expression i
Pro-protein convertase gene expression in human breast cancer
✍ Min Cheng; Peter Watson; Jean Paterson; Nabil Seidah; Michel Chrétien; Robert P. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 169 KB 👁 2 views

As a first step towards elucidating the role that pro-protein convertases play in the growth regulation of breast cancer, we studied the gene expression of 6 known human convertase members (PC1/PC3, PC2, furin/PACE, PACE4, PC5/PC6 and PC7/LPC) in human breast cancer tumors and cell lines. PC1, furin

Cancer risk in mutation carriers of DNA-
Cancer risk in mutation carriers of DNA-mismatch-repair genes
✍ Markku Aarnio; Risto Sankila; Eero Pukkala; Reijo Salovaara; Lauri A. Aaltonen; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 46 KB 👁 1 views

Excessive incidence of various cancers is a challenging feature of the hereditary-non-polyposis-colorectal-cancer (HNPCC) syndrome. This study estimated the cancer incidences in HNPCC compared with the general population. Individuals in a cohort of 1763 members of 50 genetically diagnosed families w

TP53 gene mutations in plasma DNA of can
TP53 gene mutations in plasma DNA of cancer patients
✍ Jose M. Silva; Rocio Gonzalez; Gemma Dominguez; Jose M. Garcia; Pilar España; Fe 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Using different molecular techniques, DNA has been shown to be present in plasma of patients with several types of tumors. Mutations of TP53 are the most common genetic changes in human cancers. We investigated the presence of TP53 gene mutations in plasma DNA of breast and small cell lung cancer pa

New nonsense mutation in the breast canc
New nonsense mutation in the breast cancer-1 gene in a French site-specific breast cancer family
✍ V Laplace-Marieze; N Presneau; C Girodet; V Vidal; C Vaurs; P Rio; Y-J Bignon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

Duchenne muscular dystrophy (DMD) is an X-linked degenerative disorder of muscle, caused by gross rearrangements by the dystrophin gene in two-thirds of cases. The remaining one-third of patients may carry more subtle mutations that are difficult to detect because of the large size and complexity of